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Abstract: The association between the use of cannabis and the risk
of lung cancer is unclear. A hospital-based case-control study was
conducted among men in Tunisia and included 149 incident lung
cancer cases and 188 controls. Tobacco smoking was significantly
associated with an increased risk of lung cancer with odds ratios
increasing linearly (p for trend  0.0001) from 3.9 (95% confidence
interval [CI], 1.4–10.9) for former smokers to 17.1 (95% CI:
6.3–46.3) among current smokers who had smoked for 35 years.
The odds ratio for the past use of cannabis and lung cancer was 4.1
(95% CI: 1.9–9.0) after adjustment for age, tobacco use, and
occupational exposures. No clear dose-response relationship was
observed between the risk of lung cancer and the intensity or
duration of cannabis use. This study suggests that smoking cannabis
may be a risk factor for lung cancer.
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Little is known about the association between the use ofcannabis and the risk of lung cancer.1–3 Morocco is an
important producer of cannabis in North Africa; the preva-
lence of cannabis use in the Moroccan population is around
8% according to the United Nations Office on Drugs and
Crime. Few statistics are available on the use of cannabis in
other North African countries, but it is reasonable to assume
that its prevalence in this region is relatively high. A previous
study conducted in Morocco2 concluded that, when con-
sumed alone or with snuff (tobacco powder), hashish/kiff, a
mixture of cannabis and tobacco, was associated with lung
cancer, which suggests a possible etiologic role of cannabis in
lung cancer. Therefore, a case-control study was conducted in
Tunisia to investigate the effect of cannabis use on the
etiology of lung cancer.
METHODS
A hospital-based case-control study was conducted
among men in Tunis, Tunisia, and included 149 cases of lung
cancer and 188 controls who were enrolled between March of
2000 and February of 2003. Cases were defined as patients
who had been diagnosed with primary incident lung cancer
and who were enrolled at the Salah Azaı¨z Institut (the
national cancer institute) and the Ariana Hospital. The diag-
nosis of lung cancer was confirmed by histologic or cytologic
examination except for two cases that were diagnosed only
radiographically. Controls were men hospitalized at the same
time as cases and recruited at the Salah Azaı¨z Institut, the
Ariana Hospital, and the Charles Nicole Hospital; hospital-
ization was mainly for nonmalignant diseases of the genito-
urinary system (110 controls) and endocrine, nutritional, or
metabolic diseases (28 controls). The Salah Azaı¨z Institut, the
Ariana Hospital, and the Charles Nicole Hospital cover both
urban and rural areas in Tunisia and therefore ensure a wide
recruitment of patients.
A questionnaire was used to obtain information on
sociodemographic status, tobacco and cannabis smoking hab-
its, and self-reported occupational exposures (asbestos,
nickel, arsenic). After informed consent was obtained from
each individual, the questionnaire was administered in Arabic
by a trained physician.
Tobacco smoking status was defined as never smoker,
former smoker, and current smoker of 25 years, 25–35
years, and 35 years. To avoid small numbers of patients in
cells of stratified analyses, former smoking and current smok-
ing were merged and a single cutoff of 35 years was used to
explore the effect of cannabis according to duration of to-
bacco smoking. In this study, no patients declared current use
of cannabis. Therefore, cannabis use was categorized as never
and past use. For past users, self-reported duration of canna-
bis use and the number of cannabis cigarettes smoked per day
were available. Occupational exposure was determined using
an ever-/never-exposed variable. Any individual with a his-
tory of self-reported occupational exposure to nickel and/or
asbestos and/or arsenic was considered to be ever exposed.
Unconditional logistic regression models were used to
estimate the odds ratio for lung cancer. Different models
including continuous or categorical variables for tobacco
smoking and cannabis smoking were compared using likeli-
*Tobacco and Cancer Group, International Agency for Research on Cancer,
Lyon, France; †Biostatistics Group, International Agency for Research
on Cancer, Lyon, France; ‡Carcinogen Identification and Evaluation
Group, International Agency for Research on Cancer, Lyon, France;
§Institut Salah Azaiz, Tunis, Tunisia, ¶Association Tunisienne de Lutte
contre le Cancer, Tunisia; and INSERM, French National Institute of
Health and Medical Research, Bordeaux, France.
Address for correspondence: Annie J. Sasco, M.D., Ph.D., INSERM, Unite´
de Recherche´ U 593, Universite´ Victor Segalen Bordeaux 2, 146 rue
Le´o-Saignat, Case 11, 33076 Bordeaux Cedex, France. E-mail:
annie.sasco@isped.u-bordeaux2.fr
Copyright © 2006 by the International Association for the Study of Lung
Cancer
ISSN: 1556-0864/06/0106-0577
Journal of Thoracic Oncology • Volume 1, Number 6, July 2006 577
hood ratio tests and models were selected based on goodness
of fit. In the multivariate analysis, results were adjusted for
age as a continuous variable, tobacco smoking status, and
occupational exposure. Tests for trend were used to assess
dose-response relationships. Analyses were carried out using
SAS version 8.2. Two-sided p values that were 5% were
considered to be statistically significant.
RESULTS
The description of the study population is presented in
Table 1. Controls were more frequently married than cases
(p 0.01), but no difference was observed between cases and
controls for age at interview (p  0.64), level of education
(p  0.44), area of residence (p  0.20), or occupational
activity (p 0.99). Tobacco smoking status was significantly
associated with an increased risk of lung cancer (Table 2),
with odds ratios that increased linearly (p for trend 0.0001)
from 3.9 for former smokers to 17.1 among current smokers
who had smoked for 35 years. Thirty cases and 12 controls
reported having smoked cannabis in the past, which corre-
sponded to an age-adjusted odds ratio of 3.7 (95% confidence
interval [CI]: 1.8–7.5). This association between past use of
cannabis and lung cancer remained statistically significant
after adjustment for age, tobacco smoking, and occupational
exposure (Table 2). The analysis to explore the effect of past
cannabis use according to different strata of duration of
tobacco smoking (Table 3) showed an increase in the risk of
lung cancer associated with past cannabis use among men
who had smoked for 35 years as well as among men who
had smoked for 35 years. No clear dose-response relation-
ship with the daily dose of cannabis used and the duration of
cannabis use after adjustment for age, occupational exposure
and tobacco smoking duration was observed. The odds ratios
for lung cancer for men who had smoked less than one
cannabis cigarette per day or one or more cigarettes per day
compared with never smokers were 4.0 (95% CI: 1.6–10.2)
and 4.2 (95% CI: 1.2–15.0), respectively. The odds ratios for
lung cancer for smokers who had smoked cannabis cigarettes
for 5 years or 5 years were 4.7 (95% CI: 1.7–13.2) and
3.4 (95% CI: 1.1–10.1), respectively, when compared with
never smokers of cannabis.
DISCUSSION
In agreement with the well-confirmed relationship be-
tween tobacco smoking and lung cancer,4,5 this study con-
ducted among Tunisian men showed that current smokers were
at higher risk of lung cancer than former smokers and that the
risk of lung cancer increased with duration of smoking.





Mean age at interview (SD) 57 (12) 57 (12)
Marital status
Single 23 (15%) 10 (5%)
Married 123 (83%) 170 (90%)
Separated (divorced or widow) 3 (2%) 8 (4%)
Level of education
No education 73 (49%) 80 (43%)
First level 43 (29%) 52 (28%)
Secondary level 26 (17%) 42 (22%)
University level 7 (5%) 14 (7%)
Living area
Urban 95 (64%) 133 (71%)
Rural 54 (36%) 55 (29%)
Occupational status
Active 71 (48%) 90 (48%)
Unemployed or retired 78 (52%) 98 (52%)
Occupational exposure to
Asbestos 6 (4%) 3 (2%)
Nickel 9 (6%) 6 (3%)
Arsenic 4 (3%) 10 (5%)
TABLE 2. Risk of Lung Cancer According to Duration of Tobacco Smoking and Past Cannabis Use among Tunisian Men
Cases (n  149) Controls (n 188) ORa 95% CI
Age, y (mean) 57 57 1.0 0.9–1.0
Occupational exposure
Never 137 (92%) 172 (91%) 1 Reference
Ever 12 (8%) 16 (9%) 0.7 0.3–1.7
Duration of tobacco smoking
Never 7 (5%) 46 (24%) 1 Reference
Former 31 (21%) 57 (30%) 3.9 1.4–10.9
Current
25 y 12 (8%) 21 (11%) 2.7 0.9–8.2
25–35 y 32 (21%) 32 (17%) 5.9 2.7–15.3
35 y 67 (45%) 32 (17%) 17.1 6.3–46.3
Cannabis use
Never 119 (80%) 176 (94%) 1 Reference
Past use 30 (20%) 12 (6%) 4.1 1.9–9.0
OR, odds ratio; CI, confidence interval. a OR and 95% CI were estimated using an unconditional logistic regression adjusted on all categorical variables presented in the table
as well as age entered as a continuous variable.
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Few epidemiologic studies have evaluated the associa-
tion between the use of cannabis and lung cancer.1–3 We
found a positive association between smoking cannabis cig-
arettes and lung cancer, and this finding is consistent with the
results of Sasco et al.2 and of Hsairi et al.3 who reported
higher risks of lung cancer among marijuana users compared
with nonusers. In our study, no clear dose-response relation-
ship was observed with intensity or duration of cannabis use.
Reasons for the absence of a dose-response relationship may
include measurement error of cannabis consumption, residual
confounding by tobacco smoking, and imprecise point esti-
mates due to the small number of cannabis users.
One limitation of the current study was the use of
hospital-based cases and controls. Incomplete recruitment of
cases or the recruitment of controls who were possibly not
representative of the source population of cases may have
introduced a selection bias, and it would be difficult to
quantify such a potential bias or to qualify its direction.
However, the hospitals enrolled in this study are the major
centers for the treatment of cancer patients in Tunisia, and a
spectrum of diagnoses was ensured for controls.
In addition, in the present study, no patient declared
that he currently used cannabis, and this might be explained
by the current strict narcotic legislation concerning the use of
cannabis in Tunisia. In future studies, the detection of urinary
metabolites of 9-tetrahydrocannabinol (9-THC), such as
COOH-THC and 11-hydroxy-THC, may be considered as a
validation of current cannabis use.
There is little evidence that 9-THC is mutagenic, but
there is some evidence that cannabis smoke rather than
9-THC is carcinogenic.6 In a study that compared tar,
carbon monoxide, and pH levels in smoke from marijuana
and tobacco cigarettes, higher pH and tar levels were found in
marijuana cigarettes than in tobacco cigarettes.7 Further,
cannabis cigarettes are usually composed of a mixture of
tobacco and cannabis, and the strong effects of cannabis
consumption might in part be explained by exposure to the
high levels of tar that are usually found in Tunisian tobacco
as well as possible deeper inhalation of the smoke among
cannabis users.7
In conclusion, this study suggests that the use of can-
nabis may be a risk factor for lung cancer. However, in our
study population, it was difficult to separate fully the effects
of tobacco and cannabis. Larger studies that include subjects
who smoked cannabis cigarettes without tobacco and pooled
analysis of published data are needed to evaluate the associ-
ation between use of cannabis and lung cancer.
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TABLE 3. Risk of Lung Cancer by Strata of Duration of Tobacco Smoking and Past Cannabis Use among Tunisian Men
Cases (n  149) Controls (n  188) ORa 95% CI
Tobaccob Cannabis
Never Never 7 (5%) 46 (24%) 1 Reference
35 Never 49 (33%) 77 (41%) 4.2 1.7–10.4
35 Past use 6 (4%) 6 (3%) 8.9 2.1–38.0
35 Never 63 (42%) 53 (28%) 15.3 5.6–42.3
35 Past use 24 (16%) 6 (3%) 65.0 16.7–253.1
OR, odds ratio; CI, confidence interval. a OR and 95% CI were estimated using an unconditional logistic regression adjusted on age entered as continuous variable and
occupational exposure. b Lifetime duration of tobacco use in years.
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